Version 5.4
Homo sapiens Protein: SLC41A2
Summary
InnateDB Protein IDBP-54497.6
Last Modified 2014-10-13 [Report errors or provide feedback]
Gene Symbol SLC41A2
Protein Name solute carrier family 41, member 2
Synonyms
Species Homo sapiens
Ensembl Protein ENSP00000258538
InnateDB Gene IDBG-54493 (SLC41A2)
Protein Structure
UniProt Annotation
Function Acts as a plasma-membrane magnesium transporter. {ECO:0000269PubMed:16984228}.
Subcellular Localization Cell membrane {ECO:0000269PubMed:16984228}; Multi-pass membrane protein {ECO:0000269PubMed:16984228}.
Disease Associations
Tissue Specificity
Comments
Interactions
Number of Interactions This gene and/or its encoded proteins are associated with 1 experimentally validated interaction(s) in this database.
Experimentally validated
Total 1 [view]
Protein-Protein 1 [view]
Protein-DNA 0
Protein-RNA 0
DNA-DNA 0
RNA-RNA 0
DNA-RNA 0
Gene Ontology

Molecular Function
Accession GO Term
GO:0008324 cation transmembrane transporter activity
Biological Process
GO:0006812 cation transport
GO:0055085 transmembrane transport
Cellular Component
GO:0005886 plasma membrane
GO:0016021 integral component of membrane
Protein Structure and Domains
PDB ID
InterPro IPR006667 SLC41 divalent cation transporters, integral membrane domain
PFAM PF01769
PRINTS
PIRSF
SMART
TIGRFAMs
Post-translational Modifications
Modification
Cross-References
SwissProt Q96JW4
PhosphoSite PhosphoSite-Q96JW4
TrEMBL C9JYJ7
UniProt Splice Variant
Entrez Gene 84102
UniGene Hs.713088
RefSeq NP_115524
HUGO HGNC:31045
OMIM 610802
CCDS CCDS9100
HPRD 15389
IMGT
EMBL AC089985 AC090051 AK027838 AL136828 BC036734 BC106871 BC106872
GenPept AAH36734 AAI06872 AAI06873 BAB55402 CAB66762

If you use InnateDB for your research, please cite the following publication:

Breuer et al., InnateDB: systems biology of innate immunity and beyond - recent updates and continuing curation. Nucl. Acids Res. (2013) 41 (D1) 

InnateDB is being developed jointly by the Brinkman Laboratory (Simon Fraser University, British Columbia, Canada), the Hancock Laboratory (University of British Columbia, Vancouver, British Columbia) and the Lynn EMBL Australia Group (South Australian Health & Medical Research Institute and Flinders University, Adelaide, Australia).

Funding is currently provided by Allergen and EMBL Australia. Previous funding has been provided by Genome Canada, the Foundation for the National Institutes of Health through the Grand Challenges in Global Health initiative and by Teagasc. InnateDB curated interactions are licensed under the Design Science License. All other data is licensed under the terms of the originating database. Contact: innatedb-mail@sfu.ca